findmyKOL

Robert Rope, MD

Basic profile

Oregon Health & Science University

ORCIDNPI
RegionPortland, OR · WestSpecialtyNephrologyFocusNephrology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Robert Rope is a Nephrology physician affiliated with Oregon Health & Science University. OpenAlex indexes 29 publications with 314 citations (h-index 8).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
29publications

Distinct works indexed by OpenAlex, matched via ORCID.

314citations

Total citations across indexed works.

8h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

3181 SW Sam Jackson Park Rd Mc Sjh6
Portland, OR 972393011

Telephone

503-494-7159

Registry record last updated 21 Jul 2022.

View the NPPES registry record

Industry payments

1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    77.2%
    Calcium channel blocker14.6%
    Amlodipine Besylate88%Nifedipine Er12%
    Part D<11 patients
    Loop diuretic12.6%
    Torsemide86%Furosemide14%
    Part D<11 patients

    + 11 more classes in this area

  • Metabolism & gastrointestinal

    9.2%
    Potassium supplement3%
    Potassium Chloride100%
    Part D<11 patients
    SGLT2 inhibitor1.9%
    Farxiga100%
    Part D<11 patients

    + 4 more classes in this area

  • Other

    4%
    Drugs for treatment of hyperkalemia and hyperphosphatemia2.2%
    Lokelma60%Velphoro40%
    Part D<11 patients
    Phosphate Binder1.8%
    Sevelamer Carbonate100%
    Part D<11 patients
Where care is delivered (Part B)64.9% facility · 35.1% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”